14-3-3 Inhibitors

14-3-3 inhibitors comprise a varied class of compounds, primarily including small molecule inhibitors and peptides that can disrupt the interaction of 14-3-3 proteins with their target signaling proteins. The inhibitors achieve this by either directly binding to the conserved amphipathic groove of the 14-3-3 proteins, which is the typical site for protein-protein interactions, or by modulating the signaling pathways that 14-3-3 proteins are involved in to indirectly affect their function. Peptides, such as difopein and R18, mimic the 14-3-3 binding sites on target proteins, thereby competing with natural binding partners. Small molecule inhibitors like BV02 bind directly to 14-3-3 proteins, interfering with their ability to interact with other proteins. Other compounds, such as celastrol and withaferin A, do not target 14-3-3 directly but can affect the function of 14-3-3 proteins by altering their signaling environment. For instance, by inhibiting kinases or phosphatases that modulate the phosphorylation state of 14-3-3's partners, these compounds can influence the formation or stability of 14-3-3 complexes. Similarly, compounds like chelerythrine and balanol inhibit protein kinase C and A, respectively, which may indirectly lead to the modulation of 14-3-3's interactions due to changes in phosphorylation patterns of the proteins within the related signaling pathways. These inhibitors operate through diverse mechanisms, reflecting the complex nature of the signaling networks in which 14-3-3 proteins participate.